中性粒细胞增多评估

最后审阅: 10 Nov 2024
最后更新: 08 Oct 2021

小结

鉴别诊断

常见

  • 感染
  • 炎症
  • 慢性髓细胞性白血病 (CML)
  • 原发性血小板增多症
  • 真性红细胞增多症
  • 原发性骨髓纤维化
  • 妊娠
完整详情

不常见

  • 血小板聚集
  • 冷球蛋白血症
  • 贫血
  • 恶性实体瘤
  • 骨髓浸润
  • 热射病
  • 慢性骨髓刺激
  • 无脾症
  • Sweet 综合征
  • 药源性造血
  • 慢性中性粒细胞白血病
  • 骨髓增生异常综合征
  • 急性髓系白血病
  • 遗传性中性粒细胞增多
  • Pelger-Huet 畸形
  • 无巨核细胞性血小板减少
  • 21 三体综合征(唐氏综合征)
  • I 型白细胞粘附缺陷
  • 家族性寒冷自身炎症综合征
  • 慢性特发性中性粒细胞增多
  • 应激诱发着边作用
  • 药物诱发着边作用
  • 药物诱发迁出减少
完整详情

撰稿人

作者

Devon Chabot-Richards, MD

Assistant Professor of Pathology

University of New Mexico Health Sciences Center

Albuquerque

NM

利益声明

DCR declares that she has no competing interests.

Tracy I. George, MD

Professor of Pathology

University of New Mexico Health Sciences Center

Albuquerque

NM

利益声明

TIG declares that she has received consulting fees from Wiley Blackwell as coeditor-in-chief for the International Journal of Laboratory Hematology, royalties from Wolters Kluwer for an atlas on peripheral blood smears, royalties from UpToDate, Inc. for an online chapter on automated hematology, and consulting fees from Roche Hematology.

鸣谢

Dr Devon Chabot-Richards and Dr Tracy I. George would like to gratefully acknowledge Dr Holbrook Kohrt, a previous contributor to this topic.

利益声明

HK declares that he has no competing interests.

同行评议者

Carla Wilson, MD, PhD

Professor

Department of Pathology

University of New Mexico Health Sciences Center

Albuquerque

NM

利益声明

CW declares that she has no competing interests.

Sherrie Perkins, MD, PhD

Professor of Pathology

Medical Director of Hematopathology

University of Utah Health Sciences and ARUP Laboratories

Salt Lake City

UT

利益声明

SP declares that she has no competing interests.

John Reilly, BSc, MD, FRCP, FRCPath

Consultant Haematologist

Royal Hallamshire Hospital

Professor

University of Sheffield

Sheffield

UK

利益声明

JR declares that he has no competing interests.

Priyanka Mehta, MD, MRCP, FRCPath

Consultant Haematologist

University Hospital Bristol

Bristol

UK

利益声明

PM declares that she has no competing interests.

内容使用需遵循免责声明